2.18MMarket Cap-25P/E (TTM)
3.9000High3.3000Low146.17KVolume3.3100Open4.1600Pre Close534.10KTurnover24.75%Turnover RatioLossP/E (Static)590.62KShares80.640052wk High-1.07P/B2.18MFloat Cap1.727252wk Low--Dividend TTM590.62KShs Float1884.0000Historical High--Div YieldTTM14.42%Amplitude1.7240Historical Low3.6530Avg Price1Lot Size
PainReform Stock Forum
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
PainReform (Nasdaq: PRFX) announced partial topline data from its Phase 3 clinical trial of PRF-110 for post-surgical pain management in bunionectomy patients.
The initial analysis shows statistically significant superiority over placebo in pain reduction during the first 48 hours post-surgery.
However, data for the subsequent 24-hour period, important for the primary endpoint assessment, r...
im curious what you all think
📊⚡️📊
No comment yet